Short-Term Effects of Blood Transfusions on Hepcidin in Preterm Infants

Laila Lorenz1, Katharina F Müller, Christian F Poets

  • 1Department of Neonatology, University Children's Hospital of Tx00FC;bingen, Tx00FC;bingen, Germany.

Neonatology
|August 26, 2015
PubMed

Insights

Red blood cell transfusions increase serum hepcidin (HepS) in preterm infants, but urinary hepcidin (HepU) remains unchanged. Further studies are needed to understand hepcidin regulation dynamics in this population.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology
  • Hematology

Background:

  • Hepcidin is a crucial peptide hormone for iron homeostasis.
  • It holds potential as a non-invasive marker for iron status in preterm infants.
  • Understanding factors influencing hepcidin is essential for its clinical application.

Purpose of the Study:

  • To investigate the immediate impact of red blood cell (RBC) transfusions on hepcidin levels in preterm infants.
  • To assess changes in both serum hepcidin (HepS) and urinary hepcidin (HepU) concentrations post-transfusion.

Main Methods:

  • A prospective, observational study involving very preterm infants (<32 weeks gestational age).
  • Hepcidin concentrations (HepS and HepU) and cellular indices were measured before and after clinically indicated RBC transfusions.
  • Measurements utilized competitive enzyme-linked immunosorbent assay.

Main Results:

  • Twenty preterm infants received 27 RBC transfusions.
  • Hematocrit levels significantly increased post-transfusion (p < 0.0001).
  • Serum hepcidin (HepS) concentrations showed a significant increase shortly after transfusion (p < 0.05), while urinary hepcidin (HepU) levels remained unaffected.

Conclusions:

  • Serum hepcidin concentrations rise shortly after RBC transfusion in preterm infants.
  • Urinary hepcidin does not appear to be affected by short-term RBC transfusions.
  • Long-term studies are necessary to elucidate the complex dynamics of hepcidin regulation in preterm infants.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482